About: familial hypercholesterolemia
InfographicPromoted content
INFOGRAPHIC: Call to action on Familial Hypercholesterolemia (FH)
MEPs and patient organisations call EU to action on Familial Hypercholesterolemia (FH), a genetic disease characterised by high levels of the 'bad' cholesterol in the patients.
Slovenia and Netherlands lead way in cholesterol treatment
Familial hypercholesterolemia is a disease that can be detected easily and for which treatment exists. However, in Europe, only Slovenia and the Netherlands have put in place screening for the disease. EURACTIV France reports.
High cholesterol wrongly blamed on unhealthy lifestyles
High cholesterol levels are often associated with unhealthy lifestyle choices. But in reality, up to 80% of hypercholesterolemia is genetically pre-determined. EURACTIV France reports.
Research links cholesterol to tendonitis and chronic pain
Chronic pain and tendon inflammation could be directly linked to high cholesterol, according to a study by the University of Canberra. EURACTIV Spain reports.
MEPs call for action on life-threatening genetic cholesterol
Members of the European Parliament this week hosted an event in Brussels where they called for an EU-wide strategy on Familiar Hypercholesterolemia, or FH, a genetic disease characterised by uncontrolled high cholesterol.
Cardiovascular disease: ‘Better prevention would bring big healthcare savings’
Cardiovascular diseases are still the world’s leading cause of death. Much more should be done to prevent the major risk factors, Philippe Thébault told EURACTIV France. VideoPromoted content
Cholesterol at the Heart of the Family
High cholesterol is not only the result of an unhealthy lifestyle and poor diet.
World Heart Day announcement: EU health information system coming soon
The European Commission is planning to have its pan-European health information system operational in about one year, an official told a Parliament event on World Heart Day (29 September).
Increased awareness vital in the fight against hypercholesterolemia
Promoting awareness and improving early detection of familial hypercholesterolemia (FH), a genetic condition, were the key points of an event held on 24 September. EURACTIV Italy reports.
Report: New anti-cholesterol drugs too expensive
The high price of two new anti-cholesterol drugs limits the benefits patients may see from them, according to a draft report released by a US nonprofit examining drug cost effectiveness.
Cardiologists call for new limits to ‘bad cholesterol’
SPECIAL REPORT / Researchers have called for lowering the official recommended threshold for bad cholesterol, arguing new drugs now make it possible to go below the currently accepted limit.
Data analytics take healthcare debate by storm
SPECIAL REPORT / Under constant budgetary pressure, healthcare providers have to make tough decisions on a daily basis, on where to make savings. Cost effectiveness analysis will soon become part of health policymakers’ standard toolkit to ensure the best outcome, analysts say.
World Heart Federation chief: ‘It’s unconscionable how little attention cardiovascular diseases get’
SPECIAL REPORT / Although cardiovascular diseases are still the number one killer in the world, they do not receive enough attention from policymakers due to many misconceptions, says Johanna Ralston.
New drugs to tackle ‘problematic’ cholesterol
SPECIAL REPORT / New medicines soon expected to hit the European market will allow patients to lower their levels of bad cholesterol more substantially than is currently possible, opening new avenues for tackling heart diseases.
McGuinness MEP: ‘The high cost of poor cardiovascular health is enormous’
The EU should better coordinate research on cardivascular disease and take action on industrial trans fatty acids, says Mairead McGuinness. VideoPromoted content
McKeown: Early diagnosis of FH is key
"The problem with FH has been that patients with the condition are often not diagnosed till later on in life," said Scott McKeown, Molecular Product Manager at Random Biosciences. VideoPromoted content
Heart UK: FH patient groups need to unite to influence policy
"FH is starting to take off in certain European countries," said Jules Payne, Chief Executive of Heart UK.
Catapano: Heterozygous FH is ‘most frequent monogenic disease’ in Europe
?In an interview at the European Atherosclerosis Society (EAS) Congress, Alberico L. Catapano said that Heterozygous FH is the "most frequent monogenic disease" in Europe. The University of Milan researcher called on the European Union to "urge member states to provide information to physicians in order to be able to detect to the disease" and to support additional genetic research into FH.
EU needs Europe-wide cascade testing to tackle FH, says expert
Consultant Chemical Pathologist at Birmingham's Queen Elisabeth Hospital Robert Cramb has stressed the importance of cross-country coordination in Europe to tackle Familial Hypercholesterolemia or FH, one of the commonest cardiovascular hereditable diseases in the world.
Pathologist: Cholesterol is a much bigger problem than we previously thought?
SPECIAL REPORT / Some diseases related to cholesterol are more prevalent than previously thought. Therefore, politicians have to recognise that they should be allocating more money for research and screening, says Dr. Robert Cramb.
Health experts link cholesterol to other unexpected diseases?
SPECIAL REPORT / As a silent killer, where symptoms are often invisible before it's too late, high levels of bad cholesterol do not get much attention. But researchers are making the case that the condition, which is known to cause cardiovascular diseases, can also cause brain disorders such as Alzheimer's, and dementia. InfographicPromoted content
